Claudio Zambaldo is an accomplished scientist specializing in medicinal chemistry with extensive experience in drug discovery. Currently serving as a Senior Scientist at Roche since July 2018, Claudio has developed innovative techniques for DNA-encoded chemical libraries and high-throughput synthesis methods. Previously, Claudio worked as a Research Associate at The Scripps Research Institute in Peter G. Schultz's group and completed two PhD programs at the University of Geneva and the University of Strasbourg. Earlier roles include a Research Associate position at Università degli Studi di Parma, where Claudio contributed to medicinal chemistry projects, along with a Master’s thesis focused on asymmetric total synthesis. Claudio Zambaldo holds a Dottore magistrale in Chimica Farmaceutica from Università degli Studi di Parma.
May, 2022 - present
August, 2020
July, 2018
Senior Scientist (medicinal Chemistry) at Enanta Pharmaceuticals
Senior Scientist (medicinal Chemistry) at Hexagon Bio
Senior Scientist, Medicinal Chemistry at Zentalis Pharmaceuticals
Senior Scientist Medicinal Chemistry at Cerevel Therapeutics
Senior Scientist, Medicinal Chemistry at Bayer
Access the worlds's biggest network of public org charts
Learn more